DNA repair and ultraviolet mutagenesis in cells from a new patient with Xeroderma pigmentosum group G and Cockayne syndrome resemble Xeroderma pigmentosum cells

Journal of Investigative Dermatology

Volumn 107, Issue 4, 1996, Pages 647-653

  Moriwaki, Shin Ichi ^a   Stefanini, Miria ^b   Lehmann, Alan R ^c   Hoeijmakers, Jan H J ^d   Robbins, Jay H ^a   Rapin, Isabelle ^e   Botta, Elena ^b   Tanganelli, Bianca ^b   Vermeulen, Wim ^d   Broughton, Bernard C ^c   Kraemer, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CNR   (Italy)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Photoproducts; Shuttle vector plasmid; Skin cancer; Transfection

Indexed keywords

ARTICLE; CASE REPORT; COCKAYNE SYNDROME; DNA REPAIR; HUMAN; HUMAN TISSUE; MALE; MUTAGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

EID: 10144261881     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12584287     Document Type: Article

References (49)

1. Aboussekhra A, Biggerstaff M, Shivji MKK, Vilpo JA, Moncollin V, Podust VN, Protic M, Hübscher U, Egly J-M, Wood RD: Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 80:859-868, 1995
2. Andrews AD, Barrett SF, Yoder FW, Robbins JH: Cockayne's syndrome fibroblasts have increased sensitivity to ultraviolet light but normal rates of unscheduled DNA synthesis. J Invest Dermatol 70:237-239, 1978
3. Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Ferguson-Smith WA, Morley WN: Studies of a new case of xeroderma pigmentosum (XP3BR) from complementation group G with cellular sensitivity to ionizing radiation. Carcinogenesis 1:745-751, 1980
4. Barrett SF, Robbins JH, Tarone RE, Kraemer KH: Evidence for defective repair of cyclobutane pyrimidine dimers with normal repair of other DNA photoproducts in a transcriptionally active gene transfected into Cockayne syndrome cells. Mutat Res 255:281-291, 1991
5. Bootsma D, Weeda G, Vermeulen W, Van Vuuren H, Troelstra C, Van der Spek P, Hoeijmakers J: Nucleotide excision repair syndromes: molecular basis and clinical symptoms. Philos Trans R Soc Lond [Biol] 347:75-81, 1995
6. Broughton BC, Thompson AF, Harcourt SA, Vermeulen W, Hoeijmakers JH, Botta E, Stefanini M, King MD, Weber CA, Cole J: Molecular and cellular analysis of the DNA repair defect in a patient in seroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome. Am J Hum Genet 56:167-174, 1995
7. Cantani A, Bamonte G, Bellioni P, Tucci Bamonte M, Ceccoli D, Tacconi ML: Rare syndromes. I. Cockayne syndrome: a review of the 129 cases so far reported in the literature. Riv Eur Sci Med Farmacol 9:9-17, 1987
8. Cheesbrough MJ, Kinmont PDC: Xeroderma pigmentosum - a unique variant with neurological involvement. Br J Dermatol 99:61, 1978
9. Cleaver JE, Kraemer KH: Xerodema pigmentosum and Cockayne syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.). The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, 1995, p 4393-4419
10. Flejter WL, McDaniel LD, Johns D, Friedberg EC, Schultz RA: Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Proc Natl Acad Sci USA 89:261-265, 1992
11. Gözükara EM, Parris CN, Weber CA, Salazar EP, Seidman MM, Watkins JF, Prakash L, Kraemer KH: The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. Cancer Res 54:3837-3844, 1994
12. Henning KA, Li L, Iyer N, McDaniel LD, Reagan MS, Legerski R, Schultz RA, Stefanini M, Lehmann AR, Mayne LV, Friedberg EC: The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell 82:555-564, 1995
13. Ichihashi M, Fujiwara Y, Uehara Y, Matsumoto A: A mild form of xeroderma pigmentosum assigned to complementation group G and its repair heterogeneity. J Invest Dermatol 85:284-287, 1985
14. Jaeken J, Klocker H, Schwaiger H, Bellmann R, Hirsch-Kaufmann M, Schweiger M: Clinical and biochemical studies in three patients with severe early infantile Cockayne syndrome. Hum Genet 83:339-346, 1989
15. Keijzer W, Jaspers NG, Abrahams PJ, Taylor AM, Arlett CF, Zelle B, Takebe H, Kinmont PD, Bootsma D: A seventh complementation group in excision-deficient xeroderma pigmentosum. Mutat Res 62:183-190, 1979
16. Kraemer KH: Heritable diseases with increased sensitivity to cellular injury. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds.). Dermatology in General Medicine. McGraw-Hill, New York, 1993, p 1974
17. Kraemer KH, Herlyn M, Yuspa SH, Clark WH Jr, Townsend GK, Neises GR, Hearing VJ: Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosum. Arch Dermatol 125:263-268, 1989
18. Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241-250, 1987
19. Lehmann AR: Three complementation groups in Cockayne syndrome. Mutat Res 106:347-356, 1982
20. Lehmann AR, Thompson AF, Harcourt SA, Stefanini M, Norris PG: Cockayne's syndrome: correlation of clinical features with cellular sensitivity of RNA synthesis to UV irradiation. J Med Genet 30:679-682, 1993
21. Marshall RR, Arlett CF, Harcourt SA, Broughton BA: Increased sensitivity of cell strains from Cockayne's syndrome to sister-chromatid-exchange induction and cell killing by UV light. Mutat Res 69:107-112, 1980
22. Mayne LV, Lehmann AR: Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res 42:1473-1478, 1982
23. Moriwaki S-I, Tarone RE, Kraemer KH: A potential laboratory test for dysplastic nevus syndrome: ultraviolet hypermutability of a shuttle vector plasmid. J Invest Dermatol 103:7-12, 1994
24. Moshell AN, Ganges MB, Lutzner MA, Coon HG, Barrett SF, Dupuy JM, Robbins JH: A new patient with both xeroderma pigmentosum and Cockayne syndrome establishes the new xeroderma pigmentosum complementation group H. In: Friedberg EC, Bridges BA (eds.). Cellular Responses to DNA Damage. Alan R. Liss, New York, 1983, p 209
25. Mu D, Park C-H, Matsunaga T, Hsu DS, Reardon JT, Sancar A: Reconstitution of human DNA repair excision nuclease in a highly defined system. J Biol Chem 270:2415-2418, 1995
26. Mudgett JS, MacInnes MA: Isolation of the functional human excision repair gene ERCC5 by intercosmid recombination. Genomics 8:623-633, 1990
27. Muriel WJ, Lamb JR, Lehmann AR: UV mutation spectra in cell lines from patients with Cockayne's syndrome and ataxia telangiectasia, using the shuttle vector pZ189. Mutat Res 254:119-123, 1991
28. Nance MA, Berry SA: Cockayne syndrome: review of 140 cases. Am J Med Genet 42:68-84, 1992
29. Norris PG, Hawk JL, Avery JA, Giannelli F: Xeroderma pigmentosum complementation group G - report of two cases. Br J Dermatol 116:861-806, 1987
30. Nouspikel T, Clarkson SG: Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient. Hum Mol Genet 3:963-967, 1994
31. O'Donovan A, Wood RD: Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5 [see comments]. Nature 363:1 85-188, 1993
32. Parris CN, Kraemer KH: Ultraviolet-induced mutations in Cockayne syndrome cells are primarily caused by cyclobutane dimer photoproducts while repair of other photoproducts is normal. Proc Natl Acad Sci USA 90:7260-7264, 1993
33. Protić-Sabljić M, Kraemer KH: One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc Natl Acad Sci USA 82:6622-6626, 1985
34. Protić-Sabljić M, Kraemer KH: Reduced repair of non-dimer photoproducts in a gene transfected into xeroderma pigmentosum cells. Photochem Photobiol 43:509-513, 1986
35. Robbins JH: Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration [clinical conference]. JAMA 260:384-388, 1988
36. Robbins JH, Brumback RA, Mendiones M, Barrett SF, Carl JR, Cho S, Denckla MB, Ganges MB, Gerber LH, Guthrie RA: Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form. Brain 114:1335-1361, 1991
37. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG: Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 80:221-248, 1974
38. Scott RJ, Itin P, Kleijer WJ, Kolb K, Arlett C, Muller H: Xeroderma pigmentosum-Cockayne syndrome complex in two patients: absence of skin tumors despite severe deficiency of DNA excision repair. J Am Acad Dermatol 29(suppl):883-889, 1993
39. Stefanini M, Fawcett H, Botta E, Nardo T, Lehmann AR: Genetic analysis of twenty-two patients with Cockayne syndrome. Hum Genet 97:418-423, 1996
40. Stefanini M, Giliani S, Nardo T, Marinoni S, Nazzaro V, Rizzo R, Trevisan G: DNA repair investigations in nine Italian patients affected by trichothiodystrophy. Mutat Res 273:119-125, 1992
41. Stefanini M, Lagomarsini P, Giliani S, Nardo T, Botta E, Peserico A, Kleijer WJ, Lehmann AR, Sarasin A: Genetic heterogeneity of the excision repair defect associated with trichothiodystrophy. Carcinogenesis 14:1101-1105, 1993
42. Troelstra C, Van Gool A, De Wit J, Vermeulen W, Bootsma D, Hoeijmakers JH: ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes. Cell 71:939-953, 1992
43. Venema J, Mullenders LH, Natarajan AT, van Zeeland AA, Mayne LV: The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc Natl Acad Sci USA 87:4707-4711, 1990
44. Vermeulen W, Jaeken J, Jaspers, NG, Bootsma D, Hoeijmakers JH: Xeroderma pigmentosum complementation group G associated with Cockayne syndrome. Am J Hum Genet 53:185-192, 1993
45. Vermeulen W, Scott RJ, Rodgers S, Muller HJ, Cole J, Arlett CF, Kleijer WJ, Bootsma D, Hoeijmakers JH, Weeda G: Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet 54:191-200, 1994a
46. Vermeulen W, Stefanini M, Giliani S, Hoeijmakers JH, Bootsma D: Xeroderma pigmentosum complementation group H falls into complementation group D. Mutat Res 255:201-208, 1991
47. Vermeulen W, Van Vuuren AJ, Chipoulet M, Schaeffer L, Appeldoorn E, Weeda G, Jaspers NGJ, Priestley A, Arlett CF, Lehmann AR, Stefanini M, Mezzina M, Sarasin A, Bootsma D, Egly J-M, Hoeijmakers JHJ: Three unusual repair deficiencies associated with transcription factor BTF2(TFIIH): evidence for the existence of a transcription syndrome. Cold Spring Harb Symp Quant Biol 59:317-330, 1994
48. Weber CA, Salazar EP, Stewart SA, Thompson LH: ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J 9:1437-1447, 1990
49. Weeda G, van Ham RC, Vermeulen W, Bootsma D, van der Eb AJ, Hoeijmakers JH: A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell 62:777-791, 1990